E-GetS Scales User Engagement Across SEA with EngageLabs Omnichannel AppPush & WhatsApp Business Solutions
SINGAPORE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- EngageLab, a world-leading AI-powered omnichannel…
Aerospike Database 8.0 Wins 2025 SiliconANGLE TechForward Awards
MOUNTAIN VIEW, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc., today…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients…
45/2025Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Schindellegi, Switzerland – 29 September 2025 Trifork Group AGCompany announcement no. 45/2025European…
Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars
EXOSENS SECURES MAJOR CONTRACT WITH THE SPANISH ARMY FOR 17 000 ADVANCED NIGHT…
Online Crypto Casino No Deposit Bonus 2025 | New Bitcoin Gambling Sites Real Money By Cafe Casino
New York City, NY, Sept. 28, 2025 (GLOBE NEWSWIRE) -- The expansion…
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Company Announcement Genmab to acquire Merus for USD 97.00 per share in…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
